Interferon-alpha and its deleterious effects on kidney transplant: Regarding one case;El interferón alfa y sus efectos deletéreos en el trasplante renal: A propósito de un caso

Nefrologia

Volumn 29, Issue 4, 2009, Pages 366-367

  Fraile, P ^a   Garcia Cosmes P ^a   Rosado, C ^a   Tabernero, J M ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT;

CASE REPORT; CHEMICALLY INDUCED DISORDER; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LETTER; MALE; MIDDLE AGED;

ANTIVIRAL AGENTS; GRAFT REJECTION; HUMANS; INTERFERON-ALPHA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 70449725397     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/NEFROLOGIA.2009.29.4.5258.EN.FULL     Document Type: Letter

References (5)

1. Baid-Agrawal S, Pascual M, Moradpour D, Frei U, Tolkoff-Rubin N. Hepatitis C virus infection in haemodialysis and kidney transplant patients. Rev Med Virol 2008;18(2):97-115.
2. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Clin Transplant. 2006;20(6):677-83.
3. Fabrizi F, Lunghi G, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther 2006;24(10):1413-22.
4. Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, Auchincloss H, et al. Acute humoral rejection in hepatitis Cinfected renal transplant recipients receiving antiviral therapy. Am J Transplant 2003;3(1):74-8.
5. Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002;74(4):427-37.